The grants of up to $25,000 each, cover a variety of illnesses and diseases – including several cancers, sleep disorders, kidney, eye, gut, paediatric and maternal health as well as a number of projects focusing on health and wellbeing associated with social issues.
Thanks to Flinders Foundation’s supporters, fundraisers and corporate partners for their incredible generosity.
The successful cancer research projects
- Dr Cedric Bardy – A new brain cancer model to study patient-derived glioblastoma cells in a human neuronal microenvironment
- Professor Robyn Clark – Consumer participation in the development of a patient-centred clinical pathway and modes of delivery for prevention detection and monitoring of cardiotoxicity during cancer treatment
- Associate Professor Simon Conn – Circular RNAs as Mutagens and Biomarkers in Glioblastoma
- Dr Stephen Gregory – Identifying novel targets for metabolic therapy to kill cancer cells with chromosomal instability
- Dr Julie-Ann Hulin - Novel modulation of nuclear receptor signalling by UDP-glucuronosyltransferase (UGT) enzymes in prostate and breast cancer
- Damian Hussey – Evaluation of IKZF1/BCAT1 promoter methylation in blood plasma and exosomes for potential use in clinical management of oesophageal neoplasia
- Associate Professor David Lynn – The role of gut microbiota in the efficacy and toxicity of agonistic antibody cancer immunotherapies
- Dr Robyn Meech – Expanding the functional diversity of drug metabolizing enzymes by alternative splicing
- Associate Professor Janni Petersen – Novel feedback inhibition of AMPK by TORC1 controls cell proliferation under stress
- Professor Mark Taylor – Towards the prediction of femoral fracture risk in patients with bone metastases using computational tools
- Dr Lauren Thurgood – Identification of novel biomarkers to predict response to ibrutinib in chronic lymphocytic leukaemia (CLL)